FDA approves Amgen drug for small cell lung cancer
-
The U.S. Food and Drug Administration on Thursday granted accelerated
approval to Amgen’s tarlatamab, a targeted immunotherapy for adults in the
advanced...
No posts with label population. Show all posts
No posts with label population. Show all posts
Subscribe to:
Posts (Atom)